ADTXOTCPharmaceutical PreparationsFiscal year ends December 31

Aditxt, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026

$0.00−0.00 (-16.67%)

Close on Oct 19, 2026

Market cap: $20
P/E (TTM): –
Dividend yield: –

Aditxt, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash & Equivalents	3.20	0.83	0.10	2.77	7.87	11	0.00	0.12
Short-Term Investments	–	–	–	–	–	–	0	–
Cash & Short-Term Investments	3.20	0.83	0.10	2.77	7.87	11	0.00	0.12
Receivables	0	0.04	0.41	0.53	0.09	–	–	–
Inventory	0.01	0.01	0.75	0.95	–	–	–	–
Prepaid Expenses & Other	0.62	0.00	0.22	0.50	0.46	0.15	–	–
Total Current Assets	3.82	2.00	6.91	4.74	9.42	11	0.00	–
Property, Plant & Equipment	0.88	1.55	1.90	2.32	2.27	0.80	–	–
Gross Property, Plant & Equipment	2.99	3.39	3.15	3.13	2.65	0.82	–	–
Accumulated Depreciation	-2.11	-1.84	-1.25	-0.82	-0.39	-0.02	–	–
Equity Method Investments	–	–	22	–	–	–	–	–
Operating Lease Right-of-Use Assets	1.20	1.23	2.20	3.16	–	1.26	–	–
Intangible Assets	0.00	0.01	0.01	0.11	0.21	0.32	–	–
Other Long-Term Assets	–	–	–	–	0.29	–	–	–
Total Assets	17	32	45	11	17	13	0.12	–
Accounts Payable	7.34	10	7.52	1.96	1.58	0.24	1.85	–
Accrued Expenses	0.30	1.89	0.39	–	–	–	–	–
Current Portion of Leases	0.81	0.68	1.00	1.09	–	0.39	–	–
Other Current Liabilities	–	–	–	–	–	0.01	–	–
Total Current Liabilities	12	23	26	3.64	3.61	1.23	2.98	–
Long-Term Leases	0.34	0.44	1.04	1.89	–	0.86	–	–
Operating Lease Liabilities	1.15	1.12	2.04	2.97	–	1.25	–	–
Total Liabilities	13	24	29	5.53	6.48	2.09	2.98	–
Preferred Stock	–	2.60	–	–	–	–	–	–
Common Stock	0.00	0.00	0.00	0.00	0.00	0.01	0.00	–
Additional Paid-In Capital	214	170	144	100	78	32	9.06	–
Retained Earnings	-210	-168	-128	-95	-67	-21	-12	–
Treasury Stock	-0.20	-0.20	-0.20	-0.20	-0.20	-0.20	-0.19	–
Comprehensive Income & Other	1.25	–	–	–	–	–	–	–
Shareholders' Equity	5.61	1.67	16	5.21	10	11	-2.85	-1.54
Noncontrolling Interest	-1.66	-0.58	-0.01	–	–	–	–	–
Total Equity	3.95	1.09	16	5.21	10	11	-2.85	-1.54
Total Liabilities & Equity	17	32	45	11	17	13	0.12	–
Shares Outstanding(shares)	0.02	0.00	0.00	0.00	0.00	0.00	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: 19.9%
Operating margin: -127821.4%
Net margin: -372062.4%
Return on equity, FY2025: -1183.4%

Financial strength

Current ratio: 0.06
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 2.0%

Valuation

P/E ratio: –
Price to sales: 0.00
Price to book: –
Dividend yield: –